Biophysical Characterization of Cationic Antibacterial Oligothioetheramides

Area of Science:

• Biophysical analysis
• Antimicrobial drug discovery
• Membrane biophysics

Background:

• Membrane-disrupting antibiotics, including antimicrobial peptides (AMPs) and their mimetics, represent a crucial but underexplored class of therapeutics.
• Understanding the precise mechanism of action of these agents is essential for developing novel antibacterial strategies.
• Oligothioetheramides (oligoTEAs) are synthetic compounds designed to mimic AMPs, offering a platform for mechanistic studies.

Purpose of the Study:

• To investigate the role of cationic functional groups, specifically guanidine versus amine, in the antibacterial efficacy of oligoTEAs.
• To elucidate the biophysical mechanism by which oligoTEAs interact with and disrupt bacterial membranes.
• To correlate specific molecular features with enhanced membrane disruption and antibacterial activity.

Main Methods:

• Synthesis of sequence-defined oligothioetheramides (oligoTEAs) incorporating either guanidine or amine functional groups.
• Assessment of antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
• Propidium iodide assay and fluorescence microscopy to evaluate membrane integrity and lipid aggregation.
• Surface plasmon resonance using a two-state binding model with loss to quantify binding kinetics and membrane interactions.

Main Results:

• OligoTEAs containing guanidine groups exhibited superior antibacterial activity against MRSA compared to those with amine groups.
• Biophysical assays confirmed that oligoTEAs disrupt bacterial membranes, leading to the formation of lipid aggregates.
• Surface plasmon resonance analysis indicated that guanidine groups enhance antibacterial activity by increasing the extent of lipid aggregation.

Conclusions:

• Guanidine functional groups are critical for enhancing the antibacterial potency of oligothioetheramides (oligoTEAs) against MRSA.
• The primary mechanism of action involves membrane disruption facilitated by increased lipid aggregation, driven by guanidine's cationic nature.
• These findings provide a biophysical rationale for the design of novel membrane-active antibiotics and highlight the importance of lipid aggregation.